Physician profile
Liya Thomas
NPI 1538890157
$7,551.71
in general payments reported to CMS, 2019-2025
20 companies · $3,881 in 2025
The $3,881 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $162 · 2024: $3,508 · 2025: $3,881.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,177 · Education: $374.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,177.22 |
| Education | $374.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,620.51 | 2023-2025 | |
| Sun Pharmaceutical Industries INC. | $812.51 | 2023-2025 | Absorica Ld, Winlevi |
| Janssen Biotech, INC. | $677.77 | 2024-2025 | Tremfya |
| Incyte Corporation | $662.72 | 2023-2025 | Opzelura |
| Genzyme Corporation | $644.92 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $618.62 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $615.68 | 2023-2025 | Dupixent, Libtayo |
| E.R. Squibb & Sons, L.L.C. | $500.30 | 2024-2025 | Sotyktu |
| Ucb, INC. | $349.87 | 2024-2025 | Bimzelx |
| Pfizer INC. | $289.19 | 2024-2025 | |
| Lilly USA, LLC | $188.71 | 2024-2025 | Ebglyss, Taltz, Olumiant |
| Galderma Laboratories, L.P. | $166.64 | 2024-2025 | Nemluvio |
| Amgen INC. | $105.24 | 2024-2025 | Otezla, Otezla |
| Arcutis Biotherapeutics, INC. | $90.53 | 2024-2025 | Zoryve |
| Leo Pharma INC. | $71.52 | 2025 | Adbry |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.93 | 2024 | Spevigo, Cyltezo |
| Genentech USA, INC. | $38.39 | 2024 | Erivedge |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $37.59 | 2024-2025 | Duobrii, Siliq |
| Kyowa Kirin, INC. | $17.47 | 2024 | Poteligeo |
| Organon LLC | $2.60 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Liya Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.